Sionna Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SION and other ETFs, options, and stocks.About SION
Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in researching, developing and commercializing novel medicines for cystic fibrosis.
CEOMichael Cloonan
CEOMichael Cloonan
Employees41
Employees41
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2019
Founded2019
Employees41
Employees41
SION Key Statistics
Market cap1.89B
Market cap1.89B
Price-Earnings ratio-26.51
Price-Earnings ratio-26.51
Dividend yield—
Dividend yield—
Average volume419.98K
Average volume419.98K
High today$44.84
High today$44.84
Low today$42.24
Low today$42.24
Open price$43.70
Open price$43.70
Volume1.95M
Volume1.95M
52 Week high$45.00
52 Week high$45.00
52 Week low$7.26
52 Week low$7.26
Stock Snapshot
With a market cap of 1.89B, Sionna Therapeutics(SION) trades at $42.35. The stock has a price-to-earnings ratio of -26.51.
During the trading session on 2025-12-21, Sionna Therapeutics(SION) shares reached a daily high of $44.84 and a low of $42.24. At a current price of $42.35, the stock is +0.3% higher than the low and still -5.6% under the high.
Trading volume for Sionna Therapeutics(SION) stock has reached 1.95M, versus its average volume of 419.98K.
Over the past 52 weeks, Sionna Therapeutics(SION) stock has traded between a high of $45.00 and a low of $7.26.
Over the past 52 weeks, Sionna Therapeutics(SION) stock has traded between a high of $45.00 and a low of $7.26.
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
0%
Sell
12.5%
People also own
Based on the portfolios of people who own SION. This list is generated using Robinhood data, and it’s not a recommendation.